Jason Rodriguez
About Jason Rodriguez
Jason Rodriguez serves as the Director of Ex Vivo Process Sciences at Tessera Therapeutics, where he has worked since 2021. He has a strong background in biomedicine and extensive experience in viral assay development and process optimization across various biotechnology companies.
Work at Tessera Therapeutics
Jason Rodriguez serves as the Director of Ex Vivo Process Sciences at Tessera Therapeutics, a position he has held since 2021. In this role, he focuses on developing and optimizing processes related to ex vivo gene therapies. His responsibilities include overseeing the implementation of innovative techniques to enhance therapeutic outcomes. He aims to establish a collaborative cross-functional process development program that drives efficient results within the organization.
Previous Experience at TCR2 Therapeutics Inc.
Before joining Tessera Therapeutics, Jason Rodriguez worked at TCR2 Therapeutics Inc. as the Associate Director of Process Development from 2018 to 2019. His tenure at TCR2 involved developing processes that support the advancement of cell therapies. His experience in this role contributed to his expertise in the biopharmaceutical sector.
Career at Sana Biotechnology, Inc.
Rodriguez held the position of Director of Gene Therapy at Sana Biotechnology, Inc. from 2019 to 2021. His work focused on the development of gene therapy processes, where he applied his knowledge of mammalian cell culture and viral assay development. This role further solidified his expertise in the field of gene therapy and viral vector production.
Educational Background
Jason Rodriguez earned his Doctor of Philosophy (Ph.D.) in Biomedicine from Mount Sinai School of Medicine, where he studied from 1999 to 2005. He also holds a Bachelor of Science (B.S.) in Biochemistry from SUNY Geneseo, completed from 1995 to 1999. His educational background provides a strong foundation for his work in biomedical research and process development.
Expertise in Cell Culture and Viral Assays
Rodriguez possesses extensive expertise in mammalian cell culture, including both adherent and suspension systems, as well as insect cell culture using baculovirus. He has significant experience in developing viral assays to define critical quality attributes for vector potency. His background includes work on process definition and optimization for live viral vaccines, particularly targeting herpes viruses.